SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-197046
Filing Date
2024-08-08
Accepted
2024-08-08 16:49:59
Documents
17
Period of Report
2024-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d800799d8k.htm   iXBRL 8-K 30894
2 EX-5.1 d800799dex51.htm EX-5.1 4837
3 EX-99.1 d800799dex991.htm EX-99.1 44820
4 EX-99.2 d800799dex992.htm EX-99.2 11222
8 GRAPHIC g800799g0808090034380.jpg GRAPHIC 5726
  Complete submission text file 0001193125-24-197046.txt   237553

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA agen-20240807.xsd EX-101.SCH 2856
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE agen-20240807_lab.xml EX-101.LAB 17235
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agen-20240807_pre.xml EX-101.PRE 10816
20 EXTRACTED XBRL INSTANCE DOCUMENT d800799d8k_htm.xml XML 3518
Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address 3 FORBES ROAD LEXINGTON MA 02421 781-674-4410
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 241189267
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)